Bright Minds Biosciences Inc. Common Stock
DRUGBright Minds Biosciences Inc. (DRUG) is a biotechnology company focused on developing psychedelic-inspired medicines for mental health and neurological disorders. The company leverages innovative compounds and research to create therapies aimed at providing novel treatment options for conditions such as depression, anxiety, and trauma-related disorders.
Company News
Bright Minds Biosciences strengthened its scientific advisory board with four experts in Prader-Willi Syndrome, launching a new investigational drug program targeting the rare genetic disorder. The company will evaluate existing and new treatment candidates, with initial Phase 1 studies focusing on safety and tolerability.
Bright Minds Biosciences will present at the Guggenheim Healthcare Innovation Conference and Jefferies Global Healthcare Conference in November 2025, and has granted stock options to directors, officers, and consultants.
Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss. Decibel Therapeutics, Inc. (NASDAQ: DBTX) gained 76% to $4.9150 after Regeneron announced it will acquire the company. Benitec Biopharma Inc. (NASDAQ: BNTC) jumped 75.8% to $3.3937. Be...
Penny stocks under $1 to watch this week. The post Penny Stocks To Buy? 10 Under $1 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
